CNG2B: a putative human cyclic nucleotide-gated ion channel

Details for Australian Patent Application No. 2001284884 (hide)

Owner Icagen, Incorporated

Inventors Creech, Christopher D.; Jegla, Timothy James

Agent Spruson & Ferguson

Pub. Number AU-B-2001284884

PCT Pub. Number WO02/14467

Priority 60/226,253 17.08.00 US; 09/927,267 10.08.01 US

Filing date 13 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 23 March 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

23 March 2006 Application Accepted

  Published as AU-B-2001284884

3 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001284885

2001284883-Means for enhancing print color density